Here are five observations:
1. A rising demand for minimally invasive procedures, increasing cases of nervous system diseases and a rising awareness of health will all drive the market’s growth.
2. High costs will damper the market’s growth, however.
3. Intra-ventricular neurosurgery is leading the global neuroendoscopy devices market and is expected to dominate the space in the future.
4. North America and Europe dominate the global market, supported by government initiatives.
5. Boston Scientific, Hoya, Arthrex, Olympus, KG, Conmend, C.R. Bard, Karl Storz, Aesculap, Accellent, Fujifilm Holding and Johnson &Johnson lead the market.
More articles on devices:
Lattice Biologics to launch three MAR products — 3 highlights
Bone Biologics completes $5M+ financing round: 3 things to know
RTI Surgical launches laminoplasty fixation system: 4 key notes
